Oncology

A Beacon of Hope: New Pancreatic Cancer Drug Doubles Survival

Rajeev Khandelwal’s Leafy Hope: Growing Soursop for His Mother’s Cancer Battle

D3 Bio’s First‑Line Data Shows Landmark Efficacy of Elisrasib in KRAS G12C‑Positive NSCLC

Hope in Numbers: Singapore’s Young Cancer Support Group Empowers Patients

Reliance Hospitals Announces India's First Breakthrough Cancer Treatment

AkeSO’s Lung‑Cancer Drug Shows a Survival Edge Over the Current Standard

Breakthrough Oral Pill Offers Fresh Hope for Pancreatic Cancer Patients

A Glimmer of Hope: Rewriting the Future of Pancreatic Cancer Treatment

The Power of a Second Look: Why Another Medical Opinion Can Be a Lifesaver in Cancer Care

United Front: How Dana-Farber and Firefighters Are Tackling Cancer Head-On

A Glimmer of Hope: Researchers Unveil Potentially Easier Prostate Cancer Treatment

The Molecular Revolution: How 'Grappling' Could Transform Cancer Drug Effectiveness

Natera's Q1: A Story of Robust Revenue Growth and Lingering Losses

Merck's Bold Bet: A Deep Dive into the Pipeline Powering Post-Keytruda Growth

Ivermectin's Unfulfilled Promise: A Potential Cancer Drug Quashed

A Beacon of Hope: Personalized mRNA Vaccine Targets Pancreatic Cancer Recurrence

A Beacon of Hope: Personalized mRNA Cancer Vaccine Shows Promise Against Pancreatic Cancer

A New Frontier in Cancer Treatment: The Promise of mRNA Vaccines

ALX Oncology Strengthens Leadership, Welcomes Biotech Veteran Jeff Knight as Chief Development and Operating Officer

A New Era of Hope: Revolutionizing Pancreatic Cancer Treatment

Telix and Regeneron Unite: A Groundbreaking Alliance for Radiopharmaceutical Innovation

BioNTech Navigates Shifting Tides: Q1 2026 Showcases Pipeline Progress Amidst Revenue Recalibration

Avacta Marks Pivotal Moment: First Patient Dosed in AVA6103 Cancer Trial

A New Chapter Unfolds: Cue Biopharma Announces Leadership Transition Amidst Clinical Advancements

Lantern Pharma Gears Up to Unveil Its Transformative 2025 Financial Story and Operational Triumphs

Navin Fluorine's Bold Leap: A Rs 1,400 Crore Bet on the Future of Fluorochemicals

A New Dawn in Prostate Cancer Treatment: Turbocharging the Immune System

Unlocking New Hope: BlossomHill Therapeutics Takes Aim at Toughest KRAS Cancers

A Glimmer of Hope: Beyond Cancer's Early Clinical Results Spark Optimism

A New Dawn for Breast Cancer Survivors: Quebec Pioneers Personalized Follow-Up

A Stinging Setback: Incyte's Cancer Therapy Fails to Clear FDA's High Bar

Aurora Investments Makes Bold Bet on Groundbreaking Healthcare Stock, Sets Ambitious $260 Price Target

A Ray of Hope: Russia's Melanoma Vaccine Poised for Release

AstraZeneca's Stellar Q4 Performance: Cancer Drugs Propel Growth and Investor Confidence

A Silent Killer No More? New Blood Test Offers Hope for Early Pancreatic Cancer Detection

Unlocking the Body's Internal Clock: How Timing Could Transform Cancer Treatment

The Lingering Shadow: How Pandemic Disruptions Quietly Worsened the Fight Against Cancer

A Surprising Turn: Autoimmune Side Effects Linked to Better Outcomes in Immunotherapy

Amgen's Horizon: Bradway Shares Strategic Vision with Cramer